Shanghai MicroPort EP MedTech Co., Ltd. (MicroPort® EP) was established in the Shanghai International Medical Zone on August 31, 2010. Its primary focus is on the development, manufacture, and marketing of minimally invasive medical devices for the treatment of electrophysiological diseases, including cardiac ablation catheter, diagnostic catheter, 3D navigation system etc..
| Website | https://www.everpace.com/en |
| Revenue | $18.3 million |
| Employees | 40 (18 on RocketReach) |
| Founded | 2010 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Healthcare Technology, Medical Devices, Medical Technology, Minimally Invasive, Interventional Cardiology, Heart Devices, Cardiology Devices, Device Development, Electrophysiology, Diagnostic Catheters, Medical Manufacturing, Heart Rhythm Management, Surgical Devices, Vascular Devices, Cardiac Ablation, Mapping Systems, Defibrillators |
| Competitors | Johnson & Johnson, Medtronic, Abbott, Stryker, BD, Boston Scientific, Zimmer Biomet, B. Braun Group, Terumo +39 more (view full list) |
Looking for a particular MicroPort EP employee's phone or email?
The MicroPort EP annual revenue was $18.3 million in 2026.
Onur Kircali is the Senior Director, Sales C and E Europe, Russia and C. Asia, M. East, Africa at MicroPort EP. of MicroPort EP.
18 people are employed at MicroPort EP.